azithromycin

Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services
Michaela Joanne Day, Michelle Jayne Cole, Helen Fifer, Neil Woodford, Rachel Pitt

Sexually Transmitted Infections Jun 2021, sextrans-2020-054897; DOI: 10.1136/sextrans-2020-054897
Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda
Francis Kakooza, Patrick Musinguzi, Meklit Workneh, Richard Walwema, Peter Kyambadde, Emmanuel Mande, Christopher Lubega, Jhamira M Nakasi, Reuben Kiggundu, Matthew M Hamill, Bernard S Bagaya, Mohammed Lamorde, Magnus Unemo, Yukari C Manabe

Sexually Transmitted Infections Jun 2021, 97 (4) 312-316; DOI: 10.1136/sextrans-2020-054581
Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial
Gillian Dean, Suneeta Soni, Rachel Pitt, Jonathan Ross, Caroline Sabin, Jennifer Whetham

Sexually Transmitted Infections May 2021, 97 (3) 177-182; DOI: 10.1136/sextrans-2020-054468
Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa
Jolein G E Laumen, Lieke B van Alphen, Liteboho D Maduna, Charlotte M Hoffman, Jeffrey D Klausner, Andrew Medina-Marino, Marleen M Kock, Remco P H Peters

Sexually Transmitted Infections Mar 2021, 97 (2) 152-156; DOI: 10.1136/sextrans-2019-054371
Lack of macrolide resistance in Mycoplasma genitalium infections in a cohort of pregnant women in South Africa
Remco P H Peters, Hyun-Sul Jung, Etienne E Muller, Marleen M Kock, Landon Myer, Jeffrey D Klausner, Dvora Joseph Davey

Sexually Transmitted Infections Feb 2021, sextrans-2020-054583; DOI: 10.1136/sextrans-2020-054583
High prevalence of coinfection of azithromycin-resistant Mycoplasma genitalium with other STIs: a prospective observational study of London-based symptomatic and STI-contact clinic attendees
Claire E Broad, Martina Furegato, Mark A Harrison, Marcus J Pond, NgeeKeong Tan, Sandra Okala, Sebastian S Fuller, Emma M Harding-Esch, S Tariq Sadiq

Sexually Transmitted Infections Feb 2021, 97 (1) 63-68; DOI: 10.1136/sextrans-2019-054356
Mycoplasma genitalium acquisition and macrolide resistance after initiation of HIV pre-exposure prophylaxis in men who have sex with men
Jens Tomas Van Praet, Sanne Steyaert, Stefaan Vandecasteele, Barbara Van Den Bergh, Hilde Mahieu, Stefanie De Buyser, Veerle Grootaert, Patrick Descheemaeker, Marijke Reynders

Sexually Transmitted Infections Sep 2020, 96 (6) 396-398; DOI: 10.1136/sextrans-2019-054335
Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
Mark Andrew Harrison, Emma Michele Harding-Esch, Michael Marks, Marcus James Pond, Robert Butcher, Anthony W Solomon, Liqing Zhou, NgeeKeong Tan, Achyuta V Nori, Henry Kako, Oliver Sokana, David C W Mabey, Syed Tariq Sadiq

Sexually Transmitted Infections Nov 2019, 95 (7) 522-528; DOI: 10.1136/sextrans-2018-053938
Delayed clearance of Mycoplasma genitalium following azithromycin treatment
Seamus Cook, Ruairi James Harwood Conway, Nicolas Pinto-Sander, Suneeta Soni

Sexually Transmitted Infections Aug 2019, 95 (5) 392; DOI: 10.1136/sextrans-2019-054064
S13.1 Does azithromycin have a future in the treatment of gonorrhoea and chlamydial infection?
Jane Hocking

Sexually Transmitted Infections Jul 2019, 95 (Suppl 1) A21-A22; DOI: 10.1136/sextrans-2019-sti.61

Main menu

azithromycin

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

azithromycin

Pages